Coherus BioSciences to Present at Cowen and Company Health Care Conference on March 2
February 23 2015 - 6:00PM
Coherus BioSciences, Inc. (Nasdaq:CHRS), a late-stage clinical
biologics platform company focused on the global biosimilar market,
today announced that it will present at the Cowen and Company 35th
Annual Health Care Conference on Monday, March 2 at 4:10 pm ET in
Boston.
A live and archived webcast of the presentation will be
available on the Investor Relations page of the Coherus website at
http://investors.coherus.com.
About Coherus BioSciences, Inc.
Coherus is a leading pure-play, global biosimilar company with a
focus on developing products for the major regulated markets.
Composed of a team of industry veterans with decades of experience
in bringing biologics to market, our goal is to become a worldwide
leader in the biosimilar market by leveraging our biologics
platform in key areas such as process science, analytical
characterization, protein production and clinical-regulatory
development. Coherus possesses late stage clinical products
and commercialization partnerships with multinational
pharmaceutical companies in Europe and Asia.
Biosimilars are intended for use in place of existing, branded
biologics to treat a range of chronic and often life-threatening
diseases, with the potential to reduce costs and expand patient
access. For additional information, please visit
www.coherus.com.
CONTACT: Susanna Chau
Investor Relations
Coherus BioSciences, Inc.
schau@coherus.com
+1 (650) 649-3577
Coherus BioSciences (NASDAQ:CHRS)
Historical Stock Chart
From Aug 2024 to Sep 2024
Coherus BioSciences (NASDAQ:CHRS)
Historical Stock Chart
From Sep 2023 to Sep 2024